Healthcare
Technology
Health

Glaukos

$75.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.61 (0.81%) As of 11:44 AM EDT today
+$0.61 (0.81%) Today

Why Robinhood?

You can buy or sell Glaukos and other stocks, options, ETFs, and crypto commission-free!

About GKOS

Glaukos Corporation, also called Glaukos, is an ophthalmic medical device company, which engages in the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Its Micro Invasive Glaucoma Surgery procedures are designed to reduce intraocular eye pressure by improving aqueous outflow through the natural physiologic pathway. Read More The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in San Clemente, CA.

Employees
437
Headquarters
San Clemente, California
Founded
1998
Market Cap
2.73B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
300.49K
High Today
$75.94
Low Today
$74.21
Open Price
$75.33
Volume
63.17K
52 Week High
$83.14
52 Week Low
$36.89

Collections

Healthcare
Technology
Health
Medical
Pharmaceutical
2015 IPO
US
North America

GKOS Earnings

-$0.19
-$0.11
-$0.04
$0.04
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 31, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.